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Introduction: We report a rare case of fulminant vasculitic mononeuropathy resulting in brachial diplegia, with
suspected brainstem and autonomic nervous system involvement in a patient with diabetes mellitus.
Case presentation: A 58-year-old Hispanic Caucasian man with diabetes mellitus presented with a 1-year history of
progressive bilateral upper extremity weakness, orthostatic intolerance and progressive memory decline. Diagnostic
evaluation including laboratory tests for progressive encephalopathies, systemic inflammatory and non-inflammatory
neuropathies, cerebrospinal fluid analyses, electrodiagnostic studies, and nerve biopsy were performed. Clinical
examination revealed moderate cognitive deficits on the Montreal Cognitive Assessment scale, bilateral facial weakness
and weakness of bilateral shoulder girdle and intrinsic hand muscles. Cerebrospinal fluid analyses revealed elevated
protein and an elevated immunoglobulin G synthesis rate, suggesting an immune-mediated process. Further laboratory
work up was non-diagnostic. Electrodiagnostic studies demonstrated chronic asymmetric axonal mononeuropathies
with ongoing denervation. A superficial radial nerve biopsy showed a chronic vasculitic neuropathy.
Glucocorticosteroid treatment, symptomatic pharmacologic and supportive non-pharmacologic therapies resulted in
improved clinical outcomes despite challenges with glycemic control.
Conclusions: This case report emphasizes the importance of a thorough evaluation of atypical or uncommon
neuromuscular presentations in diabetic patients without etiological presumptions. This is necessary in order to
promptly establish a diagnosis, initiate appropriate therapies and prevent irreversible nerve injury.
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hypotension, Peripheral neuropathy, VasculitisIntroduction
Diabetes mellitus is a known cause of peripheral ner-
vous system (PNS) disease. Common PNS manifesta-
tions include length-dependent distal sensory and
sensorimotor polyneuropathies (commonly known as
‘diabetic neuropathy’). Other neurologic manifestations in-
clude mononeuropathies such as carpal tunnel syndrome,
autonomic neuropathies and slow cognitive decline [1,2].
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reproduction in any medium, provided the oris an uncommon form of neuropathy in diabetics; usually
attributed to an immune-mediated process responsive to
immunosuppressants [3]. A more common cause for mo-
noneuropathy multiplex is peripheral nerve vasculitis [4-6].
This disorder may manifest clinically as an asymmetric sen-
sorimotor polyneuropathy that can be quite fulminant de-
pending on the aggressiveness of the inflammatory process.
Less frequent presentations include sequential cranial neu-
ropathies, autonomic neuropathy, pure sensory neuropa-
thies and rapid cognitive decline [7-9].
We report the case of a patient who presented with se-
vere progressive, asymmetric bilateral upper extremity
weakness (also known as brachial diplegia), associatedd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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noneuropathies and orthostatic hypotension, in the set-
ting of suboptimal diabetes mellitus control. Upper
extremity involvement while sparing the lower extrem-
ities, facial nerve involvement and the rapid cognitive
decline are atypical features of diabetic neuropathy; pro-
viding the rationale to investigate for an alternative eti-
ology. Electrophysiological testing was consistent with
chronic multiple axonal mononeuropathies with ongoing
denervation, consistent with multiple mononeuropathies.
Peripheral nerve histopathological evaluation demon-
strated small vessel vasculitis.
This case report suggests the importance of evaluating
for peripheral nerve vasculitis in diabetic patients with
non-length-dependent or multiple mononeuropathies,
particularly if restricted to the upper extremities, rather
than assume a metabolic microangiopathy. Vasculitis is a
pathological finding that significantly alters the clinical
management of PNS disease. Failure to diagnose and treat
peripheral nerve vasculitis may result in irreversible axonal
injury with associated significant morbidity. In a patient
with a combination of vasculitis and diabetes, special
care and close medical follow up is required when admin-
istering immunosuppressants, particularly corticosteroids.
Weighing risks associated with systemic immunosuppres-
sion with the potential benefits associated with accelerated
peripheral nerve recovery should be performed to max-
imize the chances for positive patient outcomes.
Case presentation
A 58-year-old Hispanic Caucasian man with diabetes
mellitus presented to the Emergency Center with a 1-year
history of progressive bilateral upper extremity weakness
and episodes of orthostatic lightheadedness. He initially
noticed weakness in his right-hand grip that gradually
progressed over the next 6 to 8 months to involve the left
hand and eventually both arms, to the extent that he
was unable to hold objects or elevate his arms. He also
complained of a tingling and burning sensation in both
hands. His family had noticed mild bilateral facial weakness,
described as reduced facial expression, without dysphagia
or dysarthria. He did not complain of any lower extremity
weakness or sensory symptoms. There was no bowel or
bladder dysfunction, and he denied any erectile dysfunction.
Prior to evaluation, he had been experiencing orthostatic
intolerance that worsened to the point that he became
non-ambulatory. His family had also noticed cognitive de-
cline over the last year, with frequent forgetfulness and slow
thought processing. On systems review, he reported mild
xerostomia and xerophthalmia without dysphagia.
A general physical examination, including cardiovascu-
lar, respiratory and abdominal systems, was normal. On
initial neurological examination, he was awake, alert and
oriented to person, place, time and situation. He had aMontreal Cognitive Assessment (MoCA) score of 16 out
of 30, with deficits primarily in the visuospatial, execu-
tive and delayed recall domains. On cranial nerve exam-
ination, he had preserved pupillary responses, visual
fields were full on confrontational testing, and he had
normal fundoscopy bilaterally. His extraocular move-
ments were preserved. He had bilateral facial weakness
(facial diplegia) and decreased subjective sensation to
light touch and pinprick in the left trigeminal nerve dis-
tribution. He did not have any hearing impairment and
his uvula and palate elevated symmetrically. He did not
have any weakness in his sternocleidomastoid, trapezius
or tongue muscles. On motor testing, there was de-
creased tone in his upper extremities, with bilateral
shoulder girdle and intrinsic hand muscle atrophy. On
confrontational strength testing (based on the six-point
Medical Research Council scale), he had normal neck
flexion and extension strength. He had near symmetric
proximal and distal weakness in the upper extremities,
with strength of two to three out of five in all muscle
groups tested, slightly worse on his right (Table 1). His
strength was normal in his lower extremities.
On multimodal sensory examination, he had subjectively
decreased sensation to light touch and pinprick in his left
radial nerve, left median nerve and right axillary nerve dis-
tributions. A sensory examination of his lower extremities
was normal. His triceps and patellar reflexes were dimin-
ished bilaterally, with preservation of his other myotactic
stretch reflexes. His plantar responses were flexor bilaterally,
and he did not demonstrate any frontal cortical release
signs. Automated blood pressure and heart rate measure-
ments performed at the bedside with postural change dem-
onstrated severe orthostatic hypotension with sympathetic
α- and β-adrenergic compromise as follows: supine blood
pressure, 142/90mmHg (mean arterial pressure, MAP,
107mmHg) with heart rate 68 beats/minute; sitting blood
pressure, 97/64mmHg (MAP 75mmHg) and heart rate 77
beats/minute; standing blood pressure, 65/40mmHg (MAP
48mmHg) and heart rate: 81 beats/minute.
His elevated serum hemoglobin A1C of 7.9% (normal 4.3
to 6.1%) was consistent with suboptimal diabetes control.
He had a normal thyroid function screen and serum vita-
min B12 levels. The results of tests for serum rapid plasma
reagin, human immunodeficiency virus antibodies and a
hepatitis panel were all negative. A screen for systemic vas-
culitides revealed an elevated anti-SSA antibody titer of
28.4EU/mL (reference range: neg <16EU/mL, equivocal 16
to 20EU/mL, positive >20EU/mL), with a normal anti-SSB
titer of 0.3EU/mL (reference range: neg <16EU/mL,
equivocal 16 to 20EU/mL, positive >20EU/mL). The results
of the following serum or blood tests were negative, non-
reactive or normal: anti-nuclear antibodies, anti-neutrophil
cytoplasmic antibodies, complement 3 and 4 levels and
rheumatoid factor titer.
Table 1 Serial confrontational motor strength testing, Montreal cognitive assessment testing, and orthostatic vitals
Muscle group Muscle strength grade –
data on initial examination
Muscle strength grade –
data at 3-month follow up
Muscle strength grade –
data at 1-year follow up
Shoulder flexors 2/5 (L), 3/5 (R) 2/5 (L), 3/5 (R) 3/5 (L), 4/5 (R)
Shoulder extensors 2/5 (L), 2/5 (R) 2/5 (L), 2/5 (R 4/5 (L), 5/5 (R)
Shoulder abductors 2/5 (L), 2/5 (R) 2–/5 (L), 2/5 (R) 2/5 (L), 5/5 (R)
Shoulder adductors 3/5 (L), 3/5 (R) 3/5 (L), 3/5 (R) 4/5 (L), 5/5 (R)
Elbow flexors 3–/5 (L), 3/5 (R) 3–/5 (L), 3/5 (R) 4/5 (L), 5/5 (R)
Elbow extensors 3/5 (L), 3/5 (R) 4–/5 (L), 4+/5 (R) 3+/5 (L), 4+/5 (R)
Wrist flexors 2/5 (L), 2/5 (R) 3/5 (L), 4/5 (R) 3/5 (L), 4/5 (R)
Wrist extensors 2/5 (L), 2/5 (R) 3–/5 (L), 4/5 (R) 3/5 (L), 4/5 (R)
Finger flexors 2/5 (L), 3/5 (R) 2+/5 (L), 4–/5(R) 3+/5 (L), 4/5 (R)
Finger extensors 3/5 (L), 3/5 (R) 2+/5 (L), 4/5(R) 3/5 (L), 3+/5 (R)
Finger abductors 2/5 (L), 3/5 (R) 2/5 (L), 3/5 (R) 2/5 (L), 3+/5 (R)
Finger adductors 3/5 (L), 3/5 (R) 3/5 (L), 3/5 (R) 3/5 (L), 3/5 (R)
MoCA score 16/30 16/30 16/30
Orthostatic vitals
Supine BP 142/90, pulse 68 BP 143/96, pulse 71 Not recorded
Sitting BP 97/64, pulse 77 BP 128/84, pulse 72 BP 132/88, pulse 73
Standing BP 65/40, pulse 81 BP 98/62, pulse 74 BP 102/70; pulse 83
Muscle strength data is based on the six-point Medical Research Council scale (0, no movement; 1, some movement with an inability to move the joint; 2,
movement of the joint but inability to overcome gravity; 3, ability to overcome gravity but not passive resistance; 4, ability to overcome partial resistance but not
full resistance; 5, normal strength).
Key: +, indicates slightly more; – indicates slightly less; BP, blood pressure (measured in mmHg); L, left; MoCA, Montreal Cognitive Assessment; R, right. Pulse
measured in beats per minute.
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with his severe brachial diplegia and orthostatic hy-
potension, an infectious, infiltrative or inflammatory dis-
order affecting his cranial nerves and cervical nerve roots
was considered. Cerebrospinal fluid analysis revealed a
normal white cell count of 1/μL (normal 0 to 5), with an
elevated protein level of 81mg/dL (normal 15 to 45mg/
dL), and glucose of 90mg/dL (normal 50 to 80mg/dL) with
serum glucose of 160mg/dL. A mildly elevated immuno-
globulin (Ig) G synthesis rate of 3.8mg/day was detected
(normal −9.9 to +3.3 mg/day), suggesting increased intra-
thecal antibody production. Magnetic resonance imaging
(MRI) of his brain with and without gadolinium contrast
was normal. MRI of his spine revealed mild spinal canal
stenosis at C5–C6 due to a small central disc protrusion
without cord compression. No changes suggestive of
spinal cord or nerve root inflammation were observed.
Nerve conduction studies (NCS; Table 2) suggested a
primary axonal neuropathy. Mild conduction velocity
slowing or prolonged distal latency, with reduced com-
pound motor action potential amplitudes are consistent
with this inference. There was no evidence of conduction
block in any of the nerves studied. The normal tibial motor
and sural sensory NCS provided evidence supporting the
non-length-dependent nature of the patient’s axonal neur-
opathy. Monopolar needle electromyography revealedmoderately severe chronic reinnervation changes in his ra-
dial, distal median, distal ulnar and axillary-innervated
muscles bilaterally, with ongoing denervation changes in
muscles innervated by his left distal median, right radial
and bilateral axillary nerves only. Monopolar needle elec-
tromyography of cranial nerve VII innervated muscles re-
vealed moderate chronic reinnervation changes bilaterally.
The electrodiagnostic data was consistent with chronic,
moderately severe, axonal mononeuropathies affecting the
patient’s radial, median, ulnar, axillary and facial nerves;
slightly worse on the left, as seen in mononeuropathy
multiplex. There was also evidence of moderately severe
chronic reinnervation changes affecting the L2–L4 myo-
tomes on the left, suggestive of subclinical lumbar radi-
culopathies (explaining his diminished knee reflexes on
examination). Secondary chronic inflammatory demyelin-
ating polyradiculoneuropathy (CIDP) is unlikely because
the clinical presentation, physical signs with preserved re-
flexes, were not consistent with CIDP, despite the elevated
protein on cerebrospinal fluid (CSF). Moreover, the
electrodiagnostic data did not meet the European Feder-
ation of Neurological Societies/Peripheral Nerve Society
criteria for CIDP.
He underwent a left superficial radial nerve biopsy that
demonstrated a chronic vasculitic neuropathy with on-
going Wallerian degeneration, and severe end-stage axonal
Table 2 Nerve conduction study data
Sensory nerve conduction studies
Nerve – Site Amplitude (μV) Distal latency (ms) Conduction velocity (m/s)
L Median – wrist 1.6 (≥10) 3.1 (≤2.8) 44.7 (≥50)
R Median – wrist NR
L Ulnar – wrist 7.5 (≥5) 2.9 (≤2.8) 48.0 (≥50)
R Ulnar – wrist 2.3 (≥5) 2.8 (≤2.8) 50.3 (≥50)
L Radial – forearm 7.3 (≥15) 2.0 (≤2.0) 50.0 (≥50)
R Radial – forearm 5.5 (≥15) 1.4 (≤2.0) 58.5 (≥50)
L Sural – calf 5.8 (>3) 3.2 (≤3.5) 43.3 (≥40)
Motor nerve conduction studies
Nerve-recording site – Stimulating site Amplitude (mV) Distal latency (ms) Conduction velocity (m/s)
L Median – APB/wrist 1.3 (≥5) 4.0 (≤4.5) 39.4 (≥50)
R Median – APB/wrist 2.3 (≥5) 4.9 (≤4.5) 42.6 (≥50)
L Ulnar – ADM/wrist 3.8 (≥5) 3.5 (≤3.5) 46.8 (≥50)
R Ulnar – ADM/wrist 4.0 (≥5) 3.4 (≤3.5) 51.4 (≥50)
L Radial – EIP/forearm 2.5 (≥2) 2.7 (≤2.9) 40.6 (≥50)
R Radial – EIP/forearm 3.4 (≥2) 2.6 (≤2.9) 47.6 (≥50)
L Facial – Nasalis/tragus 0.93 (≥1) 4.3 (≤4.2) N/A
R Facial – Nasalis/tragus 1.8 (≥1) 3.5 (≤4.2) N/A
L Tibial – AH/ankle 6.8 (≥3.5) 5.2 (≤6.0) 40.0 (≥40)
Normal values are indicated in parenthesis.
Key: ADM, abductor digiti minimi; AH, abductor halluces; APB, abductor pollicis brevis; EIP, extensor indicis proprius; L, left; N/A, not applicable; NR, not recordable;
R, right.
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nosis of vasculitic mononeuropathy multiplex. A salivary
gland biopsy (to evaluate for xerostomia) was normal.
High-dose intravenous methylprednisolone was adminis-
tered for 5 days followed by oral prednisone (1mg/kg/day)
with strict glycemic control. A liberal salt diet, >2L fluid
intake per day, JOBST® waist high compression stockings
(to provide 30 to 40mmHg pressure), and fludrocortisone
were used to treat the severe orthostatic hypotension. The
patient was discharged to a rehabilitation facility for upper
extremity physical and occupational therapy.
At 3-month follow up, the patient reported mild im-
provement in his upper extremity function, evidenced by
interval objective improvement on confrontational strength
testing (Table 1) and improved facial expression. There
was less orthostasis, with infrequent spells of postural
lightheadedness despite non-compliance with compression
stockings. The repeat MoCA score was unchanged, with
stable deficits in visuospatial, executive function and de-
layed recall, although the patient and his family had noted
a subjective improvement in his cognition. He was subse-
quently started on azathioprine, which was titrated up-
wards to a total daily dose of 2mg/kg/day alongside a
gradual prednisone wean.
At 1-year follow up, he demonstrated further improve-
ment in muscle strength (Table 1) with stable cognitivedeficits. He had further improvement in orthostatic
hypotension, and was continued on fludrocortisone. His
glycemic control had worsened with a hemoglobin A1C of
10%, and continued with a dose tapering prednisone regi-
men in addition to azathioprine. His hemoglobin A1C 1.5
years after hospital discharge was 9.2% on low-dose pred-
nisone and therapeutic azathioprine. He continues to re-
ceive specialist endocrinological care for diabetes. His
neurological examination at his most recent evaluation
was stable, with no appreciable change on confrontational
muscle strength testing.
Discussion
Our patient presented with progressive mononeuropathy
multiplex, dysautonomia and cognitive decline, with a
known history of diabetes mellitus that was suboptimally
controlled. The electrodiagnostic studies and nerve biopsy
were consistent with chronic axonal mononeuritis multi-
plex with ongoing nerve degeneration. Although diabetic
radiculoplexus neuropathy is a rare cause of brachial di-
plegia [10], this clinical sign was attributed to mo-
noneuropathy multiplex rather than bilateral brachial
plexopathies, cervical radiculopathies or anterior horn cell
disease based on the electrodiagnostic data. Distinguishing
between brachial plexopathies and multiple mono-
neuropathies by electrodiagnostic testing can be
Figure 1 Light and electron microscopy demonstrating vasculitic neuropathy. Representative photomicrographs of fixed sections obtained
from the left superficial radial nerve biopsy are shown. Hematoxylin and eosin (H&E)-stained sections demonstrate severe axonal loss with almost
complete depopulation of myelinated axons in a nerve fascicle (black arrow), (A) supported by the lack of neurofilament (NF) staining (black
arrow) on immunohistochemistry (IHC), as shown in (B). H&E-stained sections show focal vasculitis involving small vessels with transmural
lymphocytic infiltration in the epineurium (black arrow), (C), verified by CD45 (also known as leukocyte common antigen)-positive mononuclear
cell infiltrates on IHC (black arrow), (D). Electron micrographs further demonstrate the severe axonal loss (~90 to 95% of large and small
myelinated axons are no longer present) with residual myelinated axons (black arrows) and ongoing Wallerian degeneration (dark blue arrows)
seen at lower (E) and higher magnifications (F). Original magnifications: A and B: 20×, C and D: 64×, E: 1000× and F: 5000×.
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nificant variability within individual nerves and nerves de-
rived from the same trunk.
Our patient had severe orthostatic hypotension, with car-
diovascular sympathetic α- and β-adrenergic dysfunction.
Autonomic neuropathy is a well-recognized complication
of diabetes, and may be found in isolation (preclinical or
clinical) or in combination with diabetic polyneuropathy or
other non-neurologic complications of diabetes. Up to 20%
of diabetic patients may have cardiovascular autonomic
dysfunction [2]. However, an autonomic neuropathy may
also occur in patients with connective tissue disorders and
vasculitis. Studies have shown a variable range (24 to
100%) of sympathetic and parasympathetic dysfunction in
patients with autoimmune diseases [8]. In some cases, the
autonomic neuropathy may be subclinical, or present as an
initial clinical manifestation [8].
Finally, our patient also had moderate cognitive impair-
ment on initial clinical presentation, involving frontal, par-
ietal and temporal domains based on his MoCA data. A
population-based study revealed that early onset, longer
duration and greater severity of diabetes are associated
with mild cognitive impairment. This cognitive decline
was attributed to cerebral microvascular disease andsubclinical infarctions [2]. The rate of cognitive decline
observed in our patient raised the possibility for an alter-
native etiology. Although elevated CSF protein may be
seen in diabetics, the elevated intrathecal IgG synthesis
further raised our suspicion for an inflammatory or
immune-mediated etiology. Cognitive impairment has
been described in patients with small vessel vasculitis.
A small study reported that up to 30% of patients with
small vessel vasculitis developed subclinical mild cogni-
tive impairment, with mild abstract reasoning loss and
non-verbal memory impairment being common mani-
festations [9,11]. Cognitive changes may be associated
with an inflammatory encephalopathy. In support of this,
frontal executive disorder, attention deficit and affective
disorders have been described in Sjögren’s syndrome [9].
Recognizing clinical features that may support vasculitis
rather than diabetic vasculopathy is important, as ad-
junctive immunosuppressant therapy would be required
in the former and may worsen glycemic control without
clinical benefit in the latter.
An extensive evaluation for systemic causes of vasculitis
was unrevealing. Although peripheral nerve biopsies are
invasive, this procedure is indicated when there is a high
clinical suspicion for a non-systemic vasculitic neuropathy,
Zafar et al. Journal of Medical Case Reports 2013, 7:229 Page 6 of 6
http://www.jmedicalcasereports.com/content/7/1/229in atypical diabetic neuropathies or suspected additional
causes of neuropathy in diabetics [12]. Our patient met
these criteria and the superficial radial biopsy confirmed
the diagnosis of small vessel vasculitis; a diagnosis that
significantly altered clinical management. Demonstrable
clinical improvement was observed with chronic immuno-
suppressant therapy (over at least a year), in conjunction
with adjunctive glycemic control and supportive pharma-
cotherapies and rehabilitation.
Conclusions
We report an uncommon case of brachial diplegia, mul-
tiple cranial neuropathies, orthostatic hypotension and
moderate cognitive impairment with electrophysiological
evidence for chronic axonal mononeuropathy multiplex
secondary to small vessel vasculitis in a diabetic patient.
There was significant clinical improvement with high-dose
immunosuppressant therapy. Mononeuropathy multiplex
and vasculitis should be considered in diabetic patients ir-
respective of glycemic control status if these patients
present with non-length dependent, asymmetrical motor
or sensory deficits and progressive cognitive decline. Diag-
nostic confirmation is essential for the institution of ap-
propriate therapies to prevent irreversible axonal loss and
associated disability.
Consent
Written informed consent was obtained from the patient
for publication of this case report and accompanying im-
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